Back to Awarded Treatment Trials
Awarded Trial: 98-RC-325B-3
Grant ID
98-RC-325B-3
Illness
Bipolar Disorder
Primary Drug/Intervention
Buproprion
Primary Dosage
N/A
Secondary Drug Intervention
Paroxetine
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Discontinued
Investigator
Biederman
Sample Size
40
Duration of Study Period for Each Subject
N/A
Outcome Measurements
N/A
Results
Closed by Human Research Committee because of reports of possible increase in suicidal ideation reported elsewhere. Fourteen children completed the study, with 3 serious adverse events (manic symptoms; worsening depression; recurrence of preexisting ulcerative colitis).
Publication
N/A
Link
N/A
PI Name
Joseph Biederman
Degree
MD
Center
ADHD Program
Institution
Massachusetts General Hospital
Address
185 Alewife Brook Parkway, Suite 2000
City or Town
Cambridge
State or Province
MA
Zip or Postal Code
2114
Country
USA
Email Address
biederman@helix.mgh.harvard.edu